14 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18703675 | FORMULATIONS | VIGIL, TORIANA NICHOLE | 1612 | Non-Final OA | Apr 22, 2024 |
| 18703661 | FORMULATIONS | VIGIL, TORIANA NICHOLE | 1612 | Non-Final OA | Apr 22, 2024 |
| 18632964 | Imaging Agents | DONOHUE, SEAN R | 1618 | Non-Final OA | Apr 11, 2024 |
| 18282554 | FORMULATIONS COMPRISING A THERAPEUTIC PROTEIN AND AT LEAST ONE STABILIZER | KWON, JOHN SEUNGJAI | 1615 | Non-Final OA | Sep 18, 2023 |
| 18344945 | TAU-BINDING ANTIBODIES | WEIDNER, ADAM M | 1675 | Non-Final OA | Jun 30, 2023 |
| 18344930 | TAU-BINDING ANTIBODIES | WEIDNER, ADAM M | 1675 | Non-Final OA | Jun 30, 2023 |
| 18267235 | IMIDAZOPYRIDAZINE DERIVATIVES AS IL-17 MODULATORS | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Jun 14, 2023 |
| 18039498 | FORMULATIONS | SCOTLAND, REBECCA LYNN | 1615 | Final Rejection | May 31, 2023 |
| 18021005 | GENE THERAPY USING NUCLEIC ACID CONSTRUCTS COMPRISING METHYL CPG BINDING PROTEIN 2 (MECP2) PROMOTER SEQUENCES | THUESON, HANNA MARIE | 1638 | Non-Final OA | Feb 13, 2023 |
| 18152872 | Pharmaceutical Formulations | KIM, YUNSOO | 1641 | Non-Final OA | Jan 11, 2023 |
| 18045597 | Methods of Treatment Using Anti-IL-17A/F Antibodies | JIANG, DONG | 1674 | Non-Final OA | Oct 11, 2022 |
| 17907116 | AUTONOMOUS KNOB DOMAIN PEPTIDES | ALFANO, ALAN | 1641 | Non-Final OA | Sep 23, 2022 |
| 17787094 | MULTI-SPECIFIC ANTIBODIES | CHATTIN, AMY MARIE | 1643 | Final Rejection | Jun 17, 2022 |
| 17286247 | METHOD FOR THE TREATMENT OF MYASTHENIA GRAVIS | HOLTZMAN, KATHERINE ANN | 1646 | Final Rejection | Apr 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial